** Shares of medical device maker Baxter BAX.N rise 1.5% to $31.65
** BAX reports Q1 adj. profit of 55 cents per share, surpassing analysts' average estimate of 48 cents, according to data compiled by LSEG
** Co posts Q1 revenue of $2.63 billion, exceeding estimate of $2.59 billion
** BAX raises the lower end of its 2025 profit forecast range to $2.47 to $2.55 per share, compared with a prior view of $2.45 to $2.55
** Including session's moves, BAX stock up 9.02% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.